Indication
Treatment of moderate to severe plaque psoriasis in adults who are candidates for systemic therapy

Medicine details

Medicine name:
certolizumab pegol (Cimzia)
SMC ID:
SMC2132
Pharmaceutical company
UCB Pharma Ltd
BNF chapter
Skin
Submission type
Full submission
Status
Advice due date:
08 April 2019
SMC meeting date:
05 March 2019
Patient group submission deadline:
04 February 2019